Evion

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Evion

Quick Facts

Property Description
Active ingredient alpha-Tocopherol (Vitamin E)
Form Soft capsule, tablet, oral/topical oil
Pharmacological class Fat-Soluble Vitamin, Antioxidant
Common use Prevention and treatment of Vitamin E deficiency
Origin Natural (RRR-alpha-Tocopherol) or Synthetic (all-rac-alpha-Tocopherol)

Evion: Defining the Vitamin E Preparation

Evion is an established Vitamin E preparation that functions as an essential micronutrient and nutritional supplement, primarily providing the active ingredient alpha-Tocopherol. This substance is classified as a fat-soluble vitamin and falls into the antioxidant pharmacological class. It is clinically recognized for its critical role in protecting cell integrity and supporting immune functions. Since the body cannot produce it, Evion provides the necessary supplement to fulfill this fundamental dietary requirement. The product is frequently positioned for over-the-counter (OTC) use, focusing on general nutritional support needs.


Composition and General Purpose

The product is a single-ingredient preparation in which alpha-Tocopherol (or Tocopheryl Acetate) is delivered, often suspended in a lipid-based vehicle due to its fat solubility. Evion offers multiple forms, notably soft gelatin capsules and topical oil, allowing for both oral systemic supplementation and targeted topical application. While the active ingredient can be sourced as either natural or synthetic forms, the common purpose remains the same: to help tissues and cells resist oxidative stress. The antioxidant action of alpha-Tocopherol involves neutralizing unstable molecules called free radicals. Thus, the general use of Evion is to prevent or correct Vitamin E deficiency by ensuring robust cellular protection throughout the body.

What side effects are possible with Evion?

Possible Side Effects and Safety Information

Adverse Reaction Scope

Category Description
Key adverse reaction categories Adverse effects are generally non-serious, affecting the Gastrointestinal and Nervous Systems. Serious concerns are centered on the risk of hemorrhage with high, prolonged intake.
Frequency classification The frequency for most adverse reactions is typically classified as Not Known (cannot be estimated from available data) in regulatory documents.
System-organ classes involved Gastrointestinal Disorders (e.g., nausea, diarrhea, abdominal pain, flatulence) and Nervous System Disorders (e.g., headache, fatigue, blurred vision).
Serious adverse reactions Hemorrhage or increased bleeding risk is documented, especially in patients with Vitamin K deficiency or those receiving oral anticoagulants. Thrombophlebitis has been reported with very high doses.
Population-specific safety considerations Safety considerations are explicitly noted for patients concurrently using Oral Anticoagulants and those with existing Vitamin K deficiency due to the enhanced potential for bleeding.
Dose- or exposure-related patterns Serious safety risks are associated with long-term exposure at supra-nutritional doses, defined as intake significantly exceeding recommended daily levels.

Regulatory Safety Summary

Regulatory safety summary:

  • Adverse reactions are officially classified by system-organ class, with effects primarily documented in the gastrointestinal and nervous systems.
  • The frequency of common adverse reactions is often listed as Not Known in official labeling.
  • Serious adverse reactions, such as hemorrhage, are highlighted specifically in patients using oral anticoagulants.
  • Safety concerns are directly tied to the duration and level of exposure, specifically with long-term use of supra-nutritional doses.

Connection to the overall safety profile:

The official safety information structures the understanding of risks by documenting a profile where common adverse events are generally non-serious. The framework establishes that the primary safety concerns arise not from standard deficiency correction but from prolonged intake exceeding nutritional levels, emphasizing the serious, dose-dependent risk of hemorrhage in specific, susceptible patient populations.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents classify the overdose profile of alpha-Tocopherol (Evion) based on documented manifestations and required emergency actions. Overexposure, particularly from high-dose intake over a prolonged period, may lead to common, documented systemic effects.

Documented Overdose Manifestations

Symptoms associated with high-dose ingestion include gastrointestinal distress such as diarrhea, abdominal pain, stomach cramps, and nausea. Other reported effects involve the nervous system, presenting as headache, dizziness, blurred vision, fatigue, or muscle weakness.

Serious Outcomes and Urgent Action

The most significant, life-threatening outcome documented is an increased bleeding tendency (hemorrhage). This risk is compounded in patients with existing Vitamin K deficiency or those concurrently receiving oral anticoagulants.

In case of accidental overdose, individuals are mandated to seek professional assistance immediately. Regulators require contacting emergency services (e.g., 911 or local equivalent) if severe signs occur, such as collapse, seizure, trouble breathing, or the inability to be awakened. Management typically involves discontinuation of use and providing symptomatic and supportive treatment.

Therapeutic Uses of Evion

What Evion Treats: Main Uses and Benefits

Evion (alpha-Tocopherol) is a preparation used for managing and for addressing conditions that arise from a lack of this essential fat-soluble vitamin, and is considered relevant for supporting cellular integrity.

Therapeutic Focus and Symptom Domains

Evion is primarily used for managing or preventing clinical presentations stemming from Vitamin E deficiency, which generally arises in individuals with fat malabsorption disorders (e.g., cystic fibrosis, chronic cholestatic liver disease). This is commonly used across conditions presenting with acute episodes. It is applied in clinical settings that involve acute or unstable symptom patterns, providing nutritional support that supports general well-being and helps contribute to easing the overall symptom load.

The supplement plays a role in managing symptoms related to neuromuscular impairment, including helping to ease symptoms related to increased neurological or muscular activity, such as skeletal muscle weakness, painful leg cramps, and certain neurological deficits affecting coordination. Using Evion helps improve day-to-day comfort during symptomatic periods and may assist with maintaining functional stability.

Key indications include addressing or preventing Vitamin E deficiency, providing supportive relief for neuromuscular impairment, and assisting with maintaining cellular stability in systems like red blood cells.


Quick Fact Block

Quick Fact: Symptom Management Context
Target Symptoms Symptoms related to increased neurological or muscular activity, and systemic imbalance.
Context of Use Applied in settings marked by temporary physiological imbalance, specifically due to nutritional deficiency.
Patient Benefit Provides support that helps ease the overall symptom burden and may assist with maintaining functional stability.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Evion (Alpha-Tocopherol)

Category Official Regulatory Statement
Populations for whom use is allowed Generally acceptable for adults and children at Recommended Daily Allowance (RDA) levels for nutritional needs. Specifically indicated for patients with Vitamin E deficiency due to fat malabsorption disorders, such as cystic fibrosis, under medical guidance.
Populations for whom use is contraindicated Use is strictly contraindicated in patients with a known hypersensitivity or allergy to alpha-Tocopherol or to any components of the specific formulation, which may include arachis oil (peanut oil).

Eligibility and Restriction Status

Category Official Regulatory Classification
Age-related eligibility rules Adults and older adults generally show no issues at nutritional intake levels. Use is not recommended for children unless specifically directed by a physician. Certain high-dose formulations are contraindicated for specific at-risk groups, such as very low birth weight preterm newborn infants.
Pregnancy and lactation eligibility High-dose use is not recommended during pregnancy and breastfeeding due to official documentation stating the effects beyond RDA levels are not established. Use at RDA levels is generally acceptable.
Eligibility-related restrictions Use requires caution in patients with bleeding disorders, Vitamin K deficiency, a history of thrombosis, or those currently taking anticoagulant medications. Discontinuation of high-dose supplementation is typically required two weeks before surgery.
Condition-specific eligibility Caution is advised for patients with renal or hepatic impairment, or those with fat malabsorption disorders, as these conditions may affect the medicine’s effectiveness.

What should I know about interactions with other medicines?

The official regulatory documentation for Evion (alpha-Tocopherol) identifies specific interaction patterns with other medicines, particularly those affecting blood coagulation and the gastrointestinal absorption of fat-soluble agents.


Interaction Scope

Category Official Regulatory Documentation
Medicinal product categories with documented interactions Oral Anticoagulants, Antiplatelet Drugs, Lipase Inhibitors, Oral Iron Preparations, Estrogens, Anticonvulsants.
Specific interacting medicines (if explicitly listed) Warfarin, Aspirin, Orlistat, Mineral oil, Cholestyramine, Colestipol.
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic Potentiation: Increased effect of anticoagulants/antiplatelets (risk of hemorrhage). Exposure Interference: Decreased Vitamin E absorption or decreased iron absorption.
Timing-based interaction rules (if applicable) Orlistat: Must be administered two hours before or two hours after Evion to mitigate decreased absorption. Surgery: High-dose Evion should be discontinued approximately one month before elective surgical procedures.
Population-specific interaction notes (if applicable) Caution advised for patients with pre-existing Vitamin K deficiency due to the potential for increased bleeding tendency.

Official Interaction Statements

  • High doses of alpha-Tocopherol may potentiate the effect of oral anticoagulants (e.g., Warfarin), leading to an increased risk of haemorrhage.
  • Agents that interfere with fat absorption, including the lipase inhibitor Orlistat and sequestrants like Cholestyramine and mineral oil, may result in decreased absorption of the fat-soluble alpha-Tocopherol.
  • Evion is documented to decrease the intestinal absorption of certain oral iron preparations or increase their clearance.

These official statements delineate the required restrictions and necessary monitoring for co-administration, specifically emphasizing the increased risk of bleeding with certain drug classes.

Mechanism of Action

️ Core Mechanism: Lipid Phase Antioxidant Defense

alpha-Tocopherol (Evion) acts primarily as a chain-breaking antioxidant by inserting itself into the lipid bilayer of cell membranes, where it directly neutralizes highly destructive peroxyl radicals. By donating a hydrogen atom, it terminates the lipid peroxidation chain reaction, preventing damage to the vulnerable Polyunsaturated Fatty Acids (PUFAs) that define cellular structure.


Cellular Membrane Stabilization and Systemic Integrity

The termination of lipid peroxidation serves to stabilize cellular and organelle membranes, preserving their fluidity and structural integrity across all tissues. This fundamental mechanism provides localized defense to cells with high oxidative metabolism, such as those in the nervous system and muscle, and prevents the premature breakdown of red blood cells (oxidative hemolysis), a process that influences systemic biological parameters.


️ Biological Recycling and Regulatory Effects

To sustain its mechanistic activity, the oxidized alpha-Tocopherol must be regenerated back to its active form, a process that relies on a complementary interaction with water-soluble antioxidants like Vitamin C in the aqueous phase. Beyond its radical scavenging, alpha-Tocopherol also exerts secondary modulation over regulatory enzymes such as Protein Kinase C (PKC) and Phospholipase A2 ( PLA2), influencing signal transduction pathways related to cellular responsiveness.

Dosage and Administration Information

How Evion is Used: Administration and Dosing Principles

The general principles for using Evion (alpha-Tocopherol) are determined by the administration route and the specific clinical need, primarily focusing on preventing or treating Vitamin E deficiency. Administration protocols differentiate between systemic intake and topical use.


Routes and Forms of Administration

The approved routes include oral (softgel capsules, tablets, or liquid), topical (oil preparations), and parenteral (Intramuscular or Subcutaneous injection). The parenteral route is typically reserved for patients with confirmed malabsorption or when the oral route is not feasible.

Administration Route Primary Use Context
Oral Use General supplementation and routine deficiency management.
Parenteral Use Severe deficiency or malabsorption requiring specialist care.

Standard Dosing and Use Patterns

Dosing is based on the indication, ranging from a once-daily maintenance dose for supplementation (e.g., 200 IU to 400 IU) to substantially higher therapeutic doses for documented malabsorption syndromes. Therapeutic regimens for conditions like abetalipoproteinemia may require up to 50–100 mg per kg of body weight daily, which necessitates medical supervision.

Oral administration instructions specify that the fat-soluble preparation should be taken with or immediately after a meal containing fat to optimize absorption. Treatment may be a long-term, continuous plan for chronic conditions or a shorter course to correct an acute deficiency. In cases where a regular oral dose is missed, it is recommended not to take an extra dose; the patient should simply resume the usual schedule.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Evion (alpha-Tocopherol)


Evidence for Use in Confirmed Vitamin E Deficiency

The most established research on alpha-Tocopherol, the ingredient in Evion, relates to its study in individuals who have a confirmed Vitamin E deficiency. Studies exploring how symptoms change over time have included specialized interventional trials, long-term observational cohort studies, and detailed case series focused on rare conditions. These studies were applied to populations that struggle to absorb fat-soluble vitamins, such as those with cystic fibrosis, chronic liver diseases, or specific genetic disorders.

Research was evaluated for its association with changes in blood levels of the vitamin, and monitored outcomes related to functional imbalance, such as muscular weakness and neurological deficits. The findings described patterns related to the sustained observation or, in some studies, the favorable evolution of deficiency-related symptoms in these specific patient groups.

Research on Supportive Use for Neuromuscular Symptoms

Research has explored whether alpha-Tocopherol was associated with outcomes related to physical discomfort and conditions involving periods of heightened symptoms, such as certain neuromuscular issues. This evidence base relies largely on Randomized Controlled Trials (RCTs) and systematic reviews. Studies examined outcomes describing episodic or acute changes, like the frequency and intensity of leg cramps, and functional measures in chronic conditions.

The reported outcomes were mixed across the breadth of the research. Findings describe patterns observed in the studies where some trials described patterns where changes in cramp frequency were monitored. Conversely, results from larger, well-controlled trials focused on specific chronic neuromuscular diseases have often been inconsistent or inconclusive regarding primary functional outcomes when compared to control groups.

Key Limitations and Areas of Scientific Uncertainty

Evidence quality varies across studies, particularly between the definitive trials for deficiency correction and the more mixed findings from large-scale prevention research. Key limitations noted in the scientific literature include modest sample sizes in some specialized trials, and limited follow-up durations in many studies seeking to assess long-term functional changes. Research is ongoing to better characterize the appropriate populations for any potential supportive uses.

Key Studies & References

  1. Human Vitamin E Deficiency, and what is and is NOT vitamin E?
  2. Ataxia with vitamin E deficiency: MedlinePlus Genetics
  3. Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?
  4. Vitamin E (Alpha-Tocopherol): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Evion (FAQ)


Q: How long does the effect of one dose of Evion typically last in the body?

Official information indicates that the active ingredient, alpha-Tocopherol, is absorbed and distributed throughout the body. While the vitamin is stored long-term in fat tissues, studies examining the concentration in the bloodstream have reported the plasma half-life—the time it takes for half of the substance to be processed—within a range of a few hours.


Q: Is Evion available without a prescription?

Evion is a preparation of Vitamin E, which is officially classified as an essential nutrient. The product is commonly classified as a nutritional supplement, making it frequently available as an over-the-counter (OTC) product for general use.


Q: What is the recommended period of time for taking Evion?

Official guidelines establish a Tolerable Upper Intake Level (UL) for daily use, which is based on avoiding adverse effects, such as the risk of bleeding. For individuals with a confirmed deficiency, treatment may be a continuous, long-term plan. For general supplementation, official guidelines suggest that intake should be maintained below the established UL.


Q: Does Evion interact with common over-the-counter pain relievers?

Official documents caution that high doses may increase the effects of medicines that affect blood clotting, such as oral anticoagulants and certain antiplatelet drugs like aspirin. Specific warnings regarding other common pain relievers are generally not provided in regulatory information.


Q: Can Evion cause stomach upset or digestive issues?

Yes, official safety information documents list Gastrointestinal Disorders as possible adverse reactions. These effects may include stomach upset, nausea, diarrhea, flatulence, and general abdominal discomfort.


Q: Are headaches a known side effect of taking Evion?

Regulatory documents mention possible effects on the Nervous System. Within this system, headache is specifically listed as a known adverse reaction associated with the use of the product.


Q: What should I know about the long-term use of Evion?

Official information emphasizes that the primary safety concern is tied to long-term exposure at doses that exceed nutritional needs (supra-nutritional doses). This prolonged, high intake can lead to an increased risk of hemorrhage, particularly if an individual is already taking anticoagulant medication.


Q: Can Evion be taken at the same time as other vitamins?

Official information indicates that high doses of the active ingredient may interfere with the absorption of other fat-soluble vitamins, such as Vitamin A and Vitamin K. Additionally, it is documented to interfere with oral iron preparations.


Q: Does the efficacy of Evion vary between different age groups?

The official Recommended Dietary Allowance (RDA) is known to vary by age group. Scientific studies have also examined the effects of the active ingredient specifically in certain populations, such as older adults.


Q: Is it normal to feel slightly nauseous when first starting Evion?

Nausea is a documented adverse effect. However, official safety summaries often classify the frequency of common adverse reactions as Not Known, meaning the rate of occurrence cannot be estimated from available data.


Q: Do official sources discuss the discontinuation syndrome of Evion?

Official documentation does not define a formal 'discontinuation syndrome' (withdrawal effects) linked to stopping Evion. However, stopping the supplement is the primary recommended course of action if an individual experiences signs of Vitamin E excess or toxicity.


Q: Are there any common reasons why someone would stop taking Evion?

The official documentation advises stopping the supplement as the treatment for signs of Vitamin E excess or toxicity. These reasons include the development of adverse effects such as muscle weakness, fatigue, nausea, diarrhea, or an increased risk of bleeding.


Q: Can Evion change the color or frequency of urine or stool?

The body primarily excretes the active ingredient through bile and feces. Although specific changes in color or frequency of stool are not consistently documented, the product has been linked to potential minor changes in certain measured urine parameters.


Q: Is it possible to develop an allergy to Evion?

Yes, official regulatory documents list a known hypersensitivity or allergy to alpha-Tocopherol or any of the formulation’s components as a definitive contraindication for use, confirming that the potential for allergic reaction exists.


Q: Are there different versions of Evion available internationally?

The active ingredient, alpha-Tocopherol, is recognized and monitored by various international pharmaceutical bodies, such as different Pharmacopoeia standards. This confirms that different formulations of the ingredient are regulated and available across multiple countries.


Q: Are there any official warnings about driving or operating machinery while taking Evion?

Official safety information lists potential effects on the Nervous System that include fatigue and blurred vision. These documented effects may potentially impair an individual’s ability to drive or safely operate machinery.


Q: Can Evion affect the results of common lab tests?

Official information suggests the product can interfere with certain laboratory results. For example, it may cause a mild increase in urine creatinine. Additionally, specific sample handling is often required when measuring the vitamin's levels in the blood.


Q: Can men and women use Evion for the same reasons?

Yes, official guidelines from authoritative agencies establish the same Recommended Dietary Allowance (RDA) for the active ingredient for both adult men and non-pregnant women, indicating the nutritional requirement is equivalent.


Q: Is Evion considered a cure for any condition, according to regulatory bodies?

The official purpose of the medicine is described as the prevention and treatment of Vitamin E deficiency and antioxidant support. Regulatory documents do not use the term 'cure' and indicate that Vitamin E supplements are not shown to provide protection against serious diseases.


Q: Does the package insert for Evion contain information about sun sensitivity?

Research has examined the role of the active ingredient as an antioxidant in the context of photoprotection and has shown that it can absorb UV light in laboratory settings. Official product inserts, however, focus on established safety risks rather than providing general protective claims.


Q: What is the difference between a side effect and an adverse reaction for Evion?

Regulatory bodies typically define side effects as unexpected symptoms that are generally non-serious and bothersome. Adverse reactions, however, are used to refer to more severe outcomes that might require medical intervention or lead to hospitalization.


Q: What are the general expectations for benefits when taking Evion?

The purpose of the medicine is related to fulfilling a fundamental nutritional requirement. For all users, the benefit is tied to its essential function as a chain-breaking antioxidant that helps preserve cellular integrity throughout the body.

How should Evion be stored and disposed of?

Storage and Disposal of Evion Capsules

Evion capsules (alpha-Tocopherol) must be stored under specific environmental conditions to maintain stability.


Official Storage Requirements

The medicine should be kept in a dry place at or below 25 C (room temperature). It is mandatory to protect the capsules from light and avoid storing them in areas with excess heat or moisture, such as a bathroom. To maintain integrity, the capsules must be kept in the original container and the lid kept tightly closed. The product must be kept out of the sight and reach of children.

Official Disposal Protocol

Do not use the medicine after the printed expiry date. The preferred method for discarding unused or expired capsules is through an established medicine take-back program. Evion must not be flushed down the toilet. If a take-back option is unavailable, the capsules should be mixed with an undesirable substance (like dirt or coffee grounds) and sealed in a container before being placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Evion found in:

A-Z Index: